Trial Profile

A Multicenter, Open-label Study to Assess the Efficacy and Safety of Acthar Gel in Subjects With Severe Keratitis

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 20 Aug 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

20 May 2021 Results assessing the quality of life (QoL) and symptomatic improvements of treatment with Corticotropin Injection in refractory severe noninfectious keratitis, presented at the 26th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research.
03 May 2021 According to a Mallinckrodt media release, further data will be shared at the upcoming virtual International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting.
03 May 2021 According to a Mallinckrodt media release, the full results were presented in a poster at The Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com